Screening Platform of the EORTC for Clinical Trials in Advanced Colorectal Cancer "SPECTAcolor"
N/A
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Colo-rectal Cancer, Advanced Colo-rectal Cancer
Both
Colo-rectal Cancer, Advanced Colo-rectal Cancer
Trial Information
Screening Platform of the EORTC for Clinical Trials in Advanced Colorectal Cancer "SPECTAcolor"
Inclusion Criteria:
- Colo-rectal cancer (advanced or metastatic)
- Before patient registration, written informed consent must be given according to
ICH/GCP, and national/local regulations.
Exclusion Criteria:
- Absence of patient's consent
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Outcome Measure:
Tumour markers assessment
Outcome Description:
Five basic tumour markers will be tested: Kras, nras, braf, MSI and PKI3
Outcome Time Frame:
Within 1 week after patient registration
Safety Issue:
No
Authority:
Germany: Ethik-Kommission bei der Landesärztekammer Rheinland-Pfalz
Study ID:
EORTC-40CRC
NCT ID:
NCT01723969
Start Date:
January 2013
Completion Date:
February 2017
Related Keywords:
- Colo-rectal Cancer
- Advanced Colo-rectal Cancer
- Rectal Neoplasms
- Colorectal Neoplasms
Name | Location |
|---|
